Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ole K. Hejlesen
A Comparative Analysis of Machine Learning Models for the Detection of Undiagnosed Diabetes Patients
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Pharmacology Research & Perspectives
ADA American Diabetes Association DPP-4i Dipeptidyl peptidase 4 inhibitor EASD European Association for the Study of Diabetes EMA European Medicines Agency GLP-1 RA Glucagon-like peptide 1 receptor agonist MPR Medication possession ratio OAD Oral antidiabetic drug SGLT2i Sodium-glucose cotransporter 2 inhibitor SU Sulfonylurea T2D Type 2 diabetes TZD Thiazolidinedione 1 INTRODUCTION In 2021, approximately 536 million people aged 20–79 had a diagnosis of diabetes.
Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users
Epidemiology/Health Services Research Abstract OBJECTIVE The vast number of antihyperglycemic medications and growing amount of evidence make clinical decision making difficult. The aim of this study was to investigate the safety of antihyperglycemic dual and triple therapies for type 2 diabetes management with respect to major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality in a real-life clinical setting.
Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users
Original Research Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users Morten Hasselstrøm Jensen, Mads Kjolby, Ole Hejlesen, Poul Erik Jakobsen, Peter Vestergaard Abstract OBJECTIVE The vast number of antihyperglycemic medications and growing amount of evidence make clinical decision making difficult.
Causes of misdiagnosis of chronic obstructive pulmonary disease: A systematic scoping review
Publication HistoryPublished online: May 29, 2017Accepted: May 27, 2017; Received in revised form: May 16, 2017; Received: November 21, 2016;
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ole K.
Contact Ole K., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack